Patent · US Active

Pyrimidine compounds, process for their preparation and compositions containing them

US7820654B2 · kind B2 · utility

2Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2005
Grant dateOct 26, 2010
Priority date
Expiry dateJul 7, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention is directed to a compounds, methods and compositions for making the compounds and methods of treating a variety of diseases and disease states including atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by the low expression of Perlecan, comprising the administration of new heterocyclic compounds, particularly substituted pyrimidines. The present invention is directed to novel compounds represented by the general formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.